Results 71 to 80 of about 6,254 (164)

Do consumers need a ‘Bit’ more protection under Australian consumer laws? The regulatory risks and challenges of Bitcoin [PDF]

, 2018
The creation of Bitcoin, as a digital currency, has been a significant development in the world of finance, in that it provides an alternative method of payment to consumers and businesses who use Bitcoin as a means to buy or sell goods or simply as an ...
Van Der Westhuizen, Chinelle
core   +1 more source

Cost-benefit analysis of ecological networks assessed through spatial analysis of ecosystem services [PDF]

, 2012
1.The development of ecological networks could enhance the ability of species to disperse across fragmented landscapes and could mitigate against the negative impacts of climate change.
Balmford, Birch, Boitani, Brenman, Bullock, Cantarello, Crossman, Davies, de Groot, DECC, Egoh, Eycott, Fahrig, Fisher, Fuller, Jones-Walters, Jongman, Kareiva, Lawton, Naidoo, Naidoo, Nelson, Newell, Opdam, Rayment, Rouquette, Sutherland, TEEB, TEEB, The Wildlife Trusts, Treasury, Woodward   +31 more
core   +1 more source

Implementation of the I-PASS handoff program in diverse clinical environments: A multicenter prospective effectiveness implementation study. [PDF]

J Hosp Med, 2023
Starmer AJ, Spector ND, O'Toole JK, Bismilla Z, Calaman S, Campos ML, Coffey M, Destino LA, Everhart JL, Goldstein J, Graham DA, Hepps JH, Howell EE, Kuzma N, Maynard G, Melvin P, Patel SJ, Popa A, Rosenbluth G, Schnipper JL, Sectish TC, Srivastava R, West DC, Yu CE, Landrigan CP, I-PASS SHM Mentored Implementation Study Group.   +25 more
europepmc   +1 more source

The entangled pandemic: Deep incarnation in creation. [PDF]

Dialog, 2021
Simmons E.
europepmc   +1 more source

Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes. [PDF]

J Hosp Infect, 2023
Cotton S, McHugh MP, Dewar R, Haas JG, Templeton K, COVID-19 Genomics UK (COG-UK) Consortium.   +5 more
europepmc   +1 more source

Defining the clinical validity of genes reported to cause pulmonary arterial hypertension. [PDF]

Genet Med, 2023
Welch CL, Aldred MA, Balachandar S, Dooijes D, Eichstaedt CA, Gräf S, Houweling AC, Machado RD, Pandya D, Prapa M, Shaukat M, Southgate L, Tenorio-Castano J, ClinGen PH VCEP, Chung WK, International Consortium for Genetic Studies in Pulmonary Arterial Hypertension (PAH-ICON) at the Pulmonary Vascular Research Institute (PVRI).   +15 more
europepmc   +1 more source

STOCHASTIC FOOD PRICES AND SLASH-AND-BURN AGRICULTURE [PDF]

Demand and Price Analysis, Farm Management,
Barrett, Christopher B.
core   +1 more source

Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. [PDF]

Nat Microbiol, 2022
Willett BJ, Grove J, MacLean OA, Wilkie C, De Lorenzo G, Furnon W, Cantoni D, Scott S, Logan N, Ashraf S, Manali M, Szemiel A, Cowton V, Vink E, Harvey WT, Davis C, Asamaphan P, Smollett K, Tong L, Orton R, Hughes J, Holland P, Silva V, Pascall DJ, Puxty K, da Silva Filipe A, Yebra G, Shaaban S, Holden MTG, Pinto RM, Gunson R, Templeton K, Murcia PR, Patel AH, Klenerman P, Dunachie S, PITCH Consortium, COVID-19 Genomics UK (COG-UK) Consortium, Haughney J, Robertson DL, Palmarini M, Ray S, Thomson EC.   +42 more
europepmc   +1 more source

Genome sequencing and comprehensive rare-variant analysis of 465 families with neurodevelopmental disorders. [PDF]

Am J Hum Genet, 2023
Sanchis-Juan A, Megy K, Stephens J, Armirola Ricaurte C, Dewhurst E, Low K, French CE, Grozeva D, Stirrups K, Erwood M, McTague A, Penkett CJ, Shamardina O, Tuna S, Daugherty LC, Gleadall N, Duarte ST, Hedrera-Fernández A, Vogt J, Ambegaonkar G, Chitre M, Josifova D, Kurian MA, Parker A, Rankin J, Reid E, Wakeling E, Wassmer E, Woods CG, NIHR BioResource, Raymond FL, Carss KJ.   +31 more
europepmc   +1 more source

Biallelic variants of <i>ATP13A3</i> cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality. [PDF]

J Med Genet, 2022
Machado RD, Welch CL, Haimel M, Bleda M, Colglazier E, Coulson JD, Debeljak M, Ekstein J, Fineman JR, Golden WC, Griffin EL, Hadinnapola C, Harris MA, Hirsch Y, Hoover-Fong JE, Nogee L, Romer LH, Vesel S, NIHR Bioresource – Rare Diseases, Gräf S, Morrell NW, Southgate L, Chung WK.   +22 more
europepmc   +1 more source